AR026605A1 - Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos - Google Patents

Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos

Info

Publication number
AR026605A1
AR026605A1 ARP000106216A ARP000106216A AR026605A1 AR 026605 A1 AR026605 A1 AR 026605A1 AR P000106216 A ARP000106216 A AR P000106216A AR P000106216 A ARP000106216 A AR P000106216A AR 026605 A1 AR026605 A1 AR 026605A1
Authority
AR
Argentina
Prior art keywords
neuromuscular
mercapto
derivative
sureversion
pharmacos
Prior art date
Application number
ARP000106216A
Other languages
English (en)
Spanish (es)
Original Assignee
Adam Worrall Julia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241767&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR026605(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adam Worrall Julia filed Critical Adam Worrall Julia
Publication of AR026605A1 publication Critical patent/AR026605A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP000106216A 1999-11-29 2000-11-27 Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos AR026605A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99309558 1999-11-29

Publications (1)

Publication Number Publication Date
AR026605A1 true AR026605A1 (es) 2003-02-19

Family

ID=8241767

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106216A AR026605A1 (es) 1999-11-29 2000-11-27 Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos

Country Status (33)

Country Link
US (3) USRE44733E1 (enExample)
EP (1) EP1259550B1 (enExample)
JP (2) JP3880041B2 (enExample)
KR (1) KR100716524B1 (enExample)
CN (1) CN1188428C (enExample)
AR (1) AR026605A1 (enExample)
AT (1) ATE288450T1 (enExample)
AU (1) AU776536B2 (enExample)
BE (1) BE2008C047I2 (enExample)
BR (1) BRPI0015947B8 (enExample)
CA (1) CA2390463C (enExample)
CO (1) CO5251450A1 (enExample)
CY (1) CY2008018I2 (enExample)
CZ (1) CZ298206B6 (enExample)
DE (2) DE122008000068I2 (enExample)
DK (1) DK1259550T3 (enExample)
ES (1) ES2237496T3 (enExample)
FR (1) FR08C0052I2 (enExample)
HU (1) HU227451B1 (enExample)
IL (1) IL149423A0 (enExample)
LU (1) LU91501I2 (enExample)
MX (1) MXPA02004940A (enExample)
NL (1) NL300356I2 (enExample)
NO (2) NO328790B1 (enExample)
NZ (1) NZ518752A (enExample)
PE (1) PE20010902A1 (enExample)
PL (1) PL203012B1 (enExample)
PT (1) PT1259550E (enExample)
RU (1) RU2260013C2 (enExample)
SK (1) SK286282B6 (enExample)
TW (1) TWI242015B (enExample)
WO (1) WO2001040316A1 (enExample)
ZA (1) ZA200203538B (enExample)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6744471B1 (en) * 1997-12-05 2004-06-01 Olympus Optical Co., Ltd Electronic camera that synthesizes two images taken under different exposures
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
EP1333842B1 (en) * 2000-11-02 2006-08-30 Akzo Nobel N.V. Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
KR20060096490A (ko) 2003-10-31 2006-09-11 더 유니버시티 오브 캔사스 술포알킬 에테르-알킬 에테르 시클로덱스트린 유도체
EP1735326A4 (en) 2004-01-29 2011-04-20 Pinnacle Pharmaceuticals BETA-CYCLODEXTRIN DERIVATIVES AND THEIR USE AGAINST LETHAL ANTHRAX TOXIN
HUE058227T2 (hu) 2004-04-23 2022-07-28 Cydex Pharmaceuticals Inc DPI készítmény, amely szulfoalkil-éter-ciklodextrint tartalmaz
MX2007010129A (es) 2005-01-28 2007-11-16 Pinnacle Pharmaceuticals Inc Derivados de beta-ciclodextrina como agentes antibacteriales.
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
SI2335707T1 (sl) 2005-10-26 2015-09-30 Cydex Pharmaceuticals, Inc. Sestavki sulfoalkil eter ciklodekstrina in metode za njihovo pripravo
US20090069412A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched sugammadex
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
US7938283B2 (en) * 2008-06-20 2011-05-10 Grainpro, Inc. System and method for hermetic storage of agricultural commodities during shipping
WO2010053487A1 (en) 2008-11-07 2010-05-14 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
CN101591402B (zh) * 2009-05-05 2011-11-30 杭州奥默医药技术有限公司 6-脱氧砜类环糊精衍生物及其制备方法
US8492538B1 (en) 2009-06-04 2013-07-23 Jose R. Matos Cyclodextrin derivative salts
DE102010012281A1 (de) 2010-03-22 2011-09-22 Fresenius Medical Care Deutschland Gmbh Pharmazeutische Zusammensetzungen enthaltend substituiertes 6-Deoxy-6-sulfanylcyclodextrin
CN101864003B (zh) * 2010-06-11 2012-05-02 漆又毛 一种6-脱氧硫醚氨基酸环糊精衍生物的合成方法
WO2012025937A1 (en) * 2010-08-25 2012-03-01 Ramamohan Rao Davuluri Improved process for preparation of sugammadex
CN102060941B (zh) * 2010-11-26 2012-12-26 漆又毛 6-脱氧α-氨基酸衍生物环糊精及制备和应用
EP2814849B8 (en) 2012-02-15 2020-03-04 CyDex Pharmaceuticals, Inc. Manufacturing process for cyclodextrin derivatives
HK1211311A1 (en) 2012-02-28 2016-05-20 锡德克斯药物公司 Alkylated cyclodextrin compositions and processes for preparing and using the same
JP5892847B2 (ja) * 2012-04-27 2016-03-23 Ｄｏｗａホールディングス株式会社 シクロデキストリンとシリカ含有物質との複合材料、及びその製造方法、並びにガス吸着剤
GB201211153D0 (en) * 2012-06-22 2012-08-08 Farmhispania Pharmaceutical compositions
CA2888822C (en) 2012-10-22 2021-01-26 Cydex Pharmaceuticals, Inc. Alkylated cyclodextrin compositions and processes for preparing and using the same
US9879096B2 (en) * 2013-02-14 2018-01-30 Neuland Laboratories Limited Process for preparation of sugammadex sodium
WO2015179963A1 (en) 2014-05-29 2015-12-03 Uti Limited Partnership Cyclodextrin-based polyanionic and non-ionic dendrimers
PH12016502418B1 (en) 2014-06-26 2024-02-21 Maruishi Pharma Rocuronium preparation with improved stability
CN105348412B (zh) * 2014-08-22 2018-06-05 江苏恩华药业股份有限公司 一种舒更葡糖钠的纯化方法
DK3183295T3 (da) 2014-08-22 2023-08-21 Cydex Pharmaceuticals Inc Fraktioneret alkyleret cyclodextrinsammensætning og fremgangsmåder til fremstilling og anvendelse af samme
EP3939582B1 (en) 2015-03-19 2025-04-30 CyDex Pharmaceuticals, Inc. Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
CN104844732B (zh) * 2015-03-27 2017-05-03 山东滨州智源生物科技有限公司 一种舒更葡糖钠的制备方法
EP3280740A4 (en) * 2015-04-08 2019-03-27 Ling, Chang-Chun PHARMACEUTICAL COMPOSITIONS OF POLYANIONIC AND NONIONIC CYCLODEXTRIN BASED DENDRIMERS AND USES THEREOF
WO2016194001A1 (en) * 2015-05-29 2016-12-08 Alaparthi Lakshmi Prasad Processes for preparation of sugammadex and intermediates thereof
CN104922693A (zh) * 2015-06-19 2015-09-23 南开大学 一种阴离子型环糊精与抗癌药物包合物及制备方法
CA3001200A1 (en) * 2015-10-07 2017-04-13 Uti Limited Partnership Multifunctional polyanionic cyclodextrin dendrimers
EP3380554B2 (en) 2015-11-25 2023-10-18 Fresenius Kabi iPSUM S.r.l. Crystalline forms of per-chloro-gamma-cyclodextrines
ES2829236T3 (es) 2015-11-25 2021-05-31 Fresenius Kabi Ipsum S R L Procedimiento mejorado para la preparación de sugammadex y sus productos intermedios
EP3733717A3 (en) 2016-03-22 2020-12-30 Fresenius Kabi iPSUM S.r.l. An improved process for the preparation of sugammadex
JP6970184B2 (ja) * 2016-04-29 2021-11-24 アルベロン・ファーマ・ベー・フェー 凝血促進剤としてのシクロデキストリン
WO2017144734A2 (en) 2016-06-23 2017-08-31 Synthon B.V. Process for making sugammadex
EP3421503B1 (en) * 2016-06-29 2020-05-20 Beijing Creatron Institute Of Pharmaceutical Research Co., Ltd. Sugammadex preparation and purification method
US10526422B2 (en) 2016-06-29 2020-01-07 Beijing Creatron Institute Of Pharmaceutical Research Co., Ltd. Process for preparation and purification of Sugammades sodium
CN107778383B (zh) 2016-08-24 2020-03-10 王炳永 一种舒更葡糖钠的精制方法
US10385142B2 (en) 2017-01-23 2019-08-20 Scinopharm Taiwan, Ltd. Method for preparing sugammadex sodium
US20180318249A1 (en) 2017-05-03 2018-11-08 Cydex Pharmaceuticals, Inc. Composition containing cyclodextrin and busulfan
CN109021148B (zh) * 2017-06-08 2020-11-10 天津科伦药物研究有限公司 一种制备舒更葡糖钠的方法
US10442871B2 (en) * 2017-06-22 2019-10-15 Lawrence Livermore National Security, Llc Modified cyclodextrins for the selective sequestration of fentanyl related compounds and uses thereof
EP3421504B1 (en) 2017-06-30 2019-09-18 Synthon B.V. Process for making sugammadex
US10233263B1 (en) * 2017-08-23 2019-03-19 Formosa Laboratories, Inc. Method for preparation of sugammadex sodium
TWI703163B (zh) * 2017-08-23 2020-09-01 台耀化學股份有限公司 舒更葡糖鈉之製備方法及其晶型
JP7460521B2 (ja) 2017-11-27 2024-04-02 メディチェム エセ．ア． シクロデキストリン誘導体の合成のための方法
CN107892727B (zh) * 2017-11-27 2019-12-24 合肥博思科创医药科技有限公司 一种舒更葡糖钠的纯化方法
WO2019193198A1 (en) 2018-04-06 2019-10-10 Synthon B.V. Purification of sugammadex
KR102054228B1 (ko) * 2018-05-28 2019-12-10 연성정밀화학(주) 슈가마덱스 나트륨염의 제조방법
JP7461304B2 (ja) * 2018-06-07 2024-04-03 メルク・シャープ・アンド・ドーム・エルエルシー スガマデクスの製造方法
CN110615860A (zh) * 2018-06-20 2019-12-27 江苏恒瑞医药股份有限公司 一种舒更葡糖钠的纯化方法
ES3034771T3 (en) 2018-08-02 2025-08-22 Tapi Croatia Ind Ltd Solid state forms of sugammadex sodium
WO2020058987A1 (en) * 2018-09-20 2020-03-26 Natco Pharma Limited An improved process for the preparation of sugammadex sodium and its novel polymorphic form
KR20210087934A (ko) * 2018-09-27 2021-07-13 베르텐스타인 바이오파마 게엠베하 슈가마덱스의 신규한 결정질 형태
JP6950966B2 (ja) * 2018-11-01 2021-10-13 丸石製薬株式会社 スガマデクス又はその薬理学的に許容される塩含有液剤及びその製造方法
CN109824800A (zh) * 2018-12-29 2019-05-31 鼎元(天津)生物医药科技有限公司 一种选择性肌松拮抗药舒更葡萄糖钠的制备方法
CN109438591B (zh) * 2018-12-29 2021-02-09 博瑞生物医药（苏州）股份有限公司 舒更葡糖钠的制备工艺
WO2020201930A1 (en) 2019-03-29 2020-10-08 Hospira, Inc. An improved process for preparation of sugammadex acid and sugammadex sodium
CN111978435B (zh) 2019-05-22 2021-05-25 合肥博思科创医药科技有限公司 一种高纯度舒更葡糖钠的制备方法
US11324692B2 (en) 2019-07-03 2022-05-10 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions of suggamadex
WO2021039084A1 (ja) 2019-08-30 2021-03-04 テルモ株式会社 注射液製剤
RU2724900C1 (ru) * 2019-10-24 2020-06-26 Маруиси Фармасьютикал Ко., Лтд. Препарат рокурония с улучшенной стабильностью
CN111019016B (zh) * 2019-12-27 2022-02-18 武汉嘉诺康医药技术有限公司 一种舒更葡糖钠杂质的合成方法
JP2023515087A (ja) 2020-02-28 2023-04-12 メディチェム エセ．ア． スガマデクスを乾燥させるための方法
CN111714459B (zh) * 2020-06-18 2022-06-14 广州瑞尔医药科技有限公司 一种注射用舒更葡糖钠粉针剂及其制备方法
US11097023B1 (en) 2020-07-02 2021-08-24 Par Pharmaceutical, Inc. Pre-filled syringe containing sugammadex
EP3932391A1 (en) 2020-07-03 2022-01-05 Galenicum Health S.L.U. Method to prepare pharmaceutical compositions
US11446325B2 (en) * 2020-09-30 2022-09-20 Cyclolab Cyclodextrin Research And Development Laboratory Ltd. Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases
US11945788B2 (en) 2021-06-07 2024-04-02 Nuray Chemicals Private Limited Process for preparing pitolisant hydrochloride and solid-state forms thereof
CN113637097A (zh) * 2021-08-10 2021-11-12 北京恒创星远医药科技有限公司 6-全脱氧-6-全碘代-γ-环糊精晶体及其制备方法和应用
CN115708777A (zh) * 2021-08-19 2023-02-24 北京费森尤斯卡比医药有限公司 包含巯基环糊精衍生物或其可药用盐的包装药品和保存方法
CN119679816A (zh) * 2023-09-15 2025-03-25 杭州奥默医药股份有限公司 一种用于逆转苄异喹啉类肌松药的肌松拮抗药物
EP4656660A1 (en) * 2024-05-31 2025-12-03 Universidad de Almeria Alfa-, beta-, and gamma- cyclodextrin derivatives decorated with (2-mercaptoethyl)phosphonic acid branches, synthesis and applications

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3929813A (en) * 1973-12-26 1975-12-30 Interx Research Corp Novel pro-drug derivatives of pyridinium aldoxime type cholinesterase reactivators and process for preparing same
JPS52108027A (en) 1976-03-09 1977-09-10 Rikagaku Kenkyusho Anticarcinogen
US4816462A (en) 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
HU194858B (en) 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
IT1196033B (it) 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
GB8506792D0 (en) 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
JPH0819004B2 (ja) 1986-12-26 1996-02-28 日清製粉株式会社 徐放性医薬製剤
HU201783B (en) 1987-10-13 1990-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing partially methylized carboxy-acyl-beta-cyclodextrines and salts
US5017566A (en) 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5173481A (en) 1989-04-03 1992-12-22 The United States Of America As Represented By The Department Of Health And Human Services Preparation of specifically substituted cyclodextrins
HK1009335A1 (en) 1989-04-03 1999-05-28 Janssen Pharmaceutica N.V. Regioselective substitutions in cyclodextrins
SU1703657A1 (ru) * 1990-01-23 1992-01-07 Пятигорский фармацевтический институт Соединение включени диэтиламида никотиновой кислоты и @ -циклодекстрина, про вл ющее пролонгированное аналептическое действие
ES2067854T3 (es) 1990-03-15 1995-04-01 Tanabe Seiyaku Co Polisulfato de derivado de ciclodextrina y procedimiento para preparar el mismo.
US5180716A (en) 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5180176A (en) * 1991-08-08 1993-01-19 Far Great Plastics Industrial Co., Ltd. Elastic truck for roller skates
JP2556236B2 (ja) 1991-08-29 1996-11-20 田辺製薬株式会社 β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法
US5840881A (en) 1992-11-27 1998-11-24 Takeda Chemical Industries, Ltd. Composition containing a water-insoluble or slightly water-soluble compound with enhanced water-solubility
US5767112A (en) 1994-10-21 1998-06-16 Poli Industria Chimica, S.P.A. Muscle relaxant pharmaceutical compositions
AU708107B2 (en) 1994-11-04 1999-07-29 Commonwealth Scientific And Industrial Research Organisation Method for treating animals
GB2307176A (en) * 1995-11-15 1997-05-21 Todd Selwyn Everest Anti-inflammatory clathrating agents for topical use
US5935941A (en) 1997-10-24 1999-08-10 Pitha; Josef Alkylations of cyclodextrins leading to derivatives which have a ridgidly extended cavity
US5834446A (en) * 1996-06-21 1998-11-10 Queen's University At Kingston Nerve process growth modulators
JP4249282B2 (ja) 1998-02-27 2009-04-02 日本食品化工株式会社 新規シクロデキストリン誘導体及びその製造方法
DE69942317D1 (de) 1998-05-29 2010-06-10 Neurosciences Res Found Schmerzlinderung mit anandamide
WO2001012202A2 (en) * 1999-08-13 2001-02-22 Akzo Nobel N.V. Use of chemical chelators as reversal agents for drug-induced neuromuscular block
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
US20020111377A1 (en) 2000-12-22 2002-08-15 Albany College Of Pharmacy Transdermal delivery of cannabinoids
DE60211132T2 (de) 2001-02-14 2006-09-28 Akzo Nobel N.V. 2-alkylierte cyclodextrin-derivate : umkehrungsmittel von medikament-induzierter neuromuskulärer blockierung
TW200402417A (en) 2002-06-21 2004-02-16 Akzo Nobel Nv 1-[(Indol-3-yl)carbonyl]piperazine derivatives

Also Published As

Publication number Publication date
DE60017947T2 (de) 2005-06-23
NO20022522L (no) 2002-05-28
CY2008018I1 (el) 2009-11-04
EP1259550A1 (en) 2002-11-27
CA2390463C (en) 2009-02-03
TWI242015B (en) 2005-10-21
CN1188428C (zh) 2005-02-09
NO2010019I2 (no) 2012-08-27
BRPI0015947B8 (pt) 2021-07-06
ES2237496T3 (es) 2005-08-01
NL300356I1 (nl) 2008-10-01
US6949527B2 (en) 2005-09-27
CZ298206B6 (cs) 2007-07-18
USRE44733E1 (en) 2014-01-28
DE60017947D1 (de) 2005-03-10
PL203012B1 (pl) 2009-08-31
LU91501I9 (enExample) 2019-01-02
PT1259550E (pt) 2005-05-31
KR100716524B1 (ko) 2007-05-10
NZ518752A (en) 2003-03-28
HUP0203755A3 (en) 2003-10-28
AU5438001A (en) 2001-06-12
NO20022522D0 (no) 2002-05-28
PE20010902A1 (es) 2001-09-06
JP2003515623A (ja) 2003-05-07
HU227451B1 (en) 2011-06-28
BE2008C047I2 (enExample) 2019-12-11
CO5251450A1 (es) 2003-02-28
JP2006348301A (ja) 2006-12-28
JP4563972B2 (ja) 2010-10-20
CN1402737A (zh) 2003-03-12
LU91501I2 (fr) 2009-01-26
CZ20021814A3 (cs) 2002-08-14
WO2001040316A1 (en) 2001-06-07
PL356097A1 (en) 2004-06-14
DE122008000068I2 (de) 2011-06-16
AU776536B2 (en) 2004-09-16
MXPA02004940A (es) 2003-05-23
CA2390463A1 (en) 2001-06-07
NL300356I2 (nl) 2009-04-01
SK286282B6 (sk) 2008-06-06
BRPI0015947B1 (pt) 2012-02-07
IL149423A0 (en) 2002-11-10
SK7262002A3 (en) 2002-11-06
BRPI0015947A (pt) 2002-08-20
ATE288450T1 (de) 2005-02-15
EP1259550B1 (en) 2005-02-02
HUP0203755A2 (hu) 2003-04-28
FR08C0052I1 (enExample) 2009-02-27
RU2260013C2 (ru) 2005-09-10
ZA200203538B (en) 2003-08-04
DE122008000068I1 (de) 2009-04-23
NO328790B1 (no) 2010-05-18
US6670340B1 (en) 2003-12-30
CY2008018I2 (el) 2009-11-04
FR08C0052I2 (fr) 2009-12-18
DK1259550T3 (da) 2005-04-25
JP3880041B2 (ja) 2007-02-14
US20040029833A1 (en) 2004-02-12
KR20020063900A (ko) 2002-08-05
HK1049489A1 (en) 2003-05-16
NO2010019I1 (no) 2010-11-22

Similar Documents

Publication Publication Date Title
AR026605A1 (es) Un derivado de 6-mercapto-ciclodextrina, su uso, una composicion farmaceutica que lo comprende, un kit para proporcionar bloqueo neuromuscular y sureversion, y un metodo para la reversion del bloqueo neuromuscular inducido por farmacos
LU91160I2 (fr) Ezetimible ou ses sels acceptés en combinaison avec Simvastatin (Inegy/Vytorin).
LU92146I2 (fr) Dasatinib et ses sels pharmaceutiquement acceptables
EA200400432A1 (ru) Производные мочевины
FI915282A0 (fi) Mono-n-substituerade 1,4,7,10-tetra -azacyklododekanderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska aemnen.
AR048652A1 (es) 4-fenilamino-quinazolin-6-il-amidas
ES2079534T3 (es) Derivados de polietilenglicol, sus peptidos modificados, metodos para producirlos y uso de los peptidos modificados.
CY1106674T1 (el) Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους
FI841181A0 (fi) Nya n-fenyl-n'- cykloalkylalkanoylpiperaziner och foerfarande foer deras framstaellning.
CY1110694T1 (el) Μεθοδος παρασκευης παραγωγων της εχινοκανδινης
AR022423A1 (es) Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
NO990583D0 (no) Cykliske eterforbindelser som natriumkanalmodulatorer
AR025103A1 (es) Quelantes quimicos para la reversion del bloqueo neuromuscular inducido por farmacos
CY1105047T1 (el) Ενωσεις πυριδοπυριμιδινονης, η μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τις περιεχουν
DE60316672D1 (de) Polycyclische verbindungen als potenten alpha2-adrenoceptor antagonisten
ES2187025T3 (es) Nuevos agentes quelantes de hierro (iii) activos via oral.
AR030203A1 (es) Derivados de carbamato de 2-(s)-hidroximutilina, composiciones farmaceuticas que los comprenden, procedimiento para prepararlos y 2(s), 11-dihidroxi protegida-mutilina como compuesto intermediario
BR9708639A (pt) Composição estabilizadora
IT1317048B1 (it) Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie
BR9812892A (pt) 2 4-diamino-1,3,5-triazinas substituìdas e seu emprego como herbicidas
AR017851A1 (es) Composicion farmaceutica que comprende un eter carboxialquilico y una estatina, primera composicion farmaceutica para el uso con una segunda composicionfarmaceutica para lograr un efecto hipolipidemico y controlar el riesgo cardiaco adverso en un mamifero y conjunto para lograr dichos efectos terape
AR053987A1 (es) Derivados de malonamida. proceso de obtencion y composiciones farmaceuticas.
BR0308018A (pt) Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo
PT1197485E (pt) Derivados de ciclobuteno-diona e a sua utilizacao no tratamento da aterosclerose
DK1257552T3 (da) Xanthinderivater, mellemprodukter og anvendelse til behandling af osteoporose

Legal Events

Date Code Title Description
FG Grant, registration